Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Baseline characteristics of the 109 newly diagnosed patients with IBS

From: Poor prognostic factors in patients with newly diagnosed intestinal Adamantiades-Behçet’s disease in the Shanghai Adamantiades-Behçet’s disease database: a prospective cohort study

 All newly diagnosed IBS patientsIBS with ileocecal
ulcers
IBS with colorectum
ulcers
IBS with both ileocecal and colorectum ulcersP
N (%)10966 (60.55)19 (17.43)24 (22.02)
Follow-up, median (IQR) months28.00 (14.00–46.00)27.00 (12.00–47.50)29.00 (11.00–46.00)29.00 (20.25–42.75)
Male Sex, no. (%)57 (52.29)31 (46.97)11 (57.89)15 (62.50)0.370
Age at the diagnosis of BS, median (IQR) years35.00 (25.00–50.00)33.00 (25.00–48.75)34.00 (19.00–48.00)46.50 (28.25–52.25)0.028
Onset of BS, median (IQR) years7.00 (3.00–10.00)7.50 (4.00–10.00)7.00 (2.00–18.00)6.50 (2.25–10.75)0.780
Oral ulceration, no. (%)106 (92.25)64 (96.97)18 (94.74)24 (100.00)0.564
Genital ulcer, no. (%)75 (68.81)47 (71.21)13 (68.42)15 (62.50)0.732
Skin manifestations, no. (%)
erythema nodosum28 (25.69)15 (22.73)7 (36.84)6 (25.00)0.461
epifolliculitis30 (27.52)20 (30.30)5 (26.32)5 (20.83)0.668
Positive pathergy reaction3 (2.75)3 (4.55)0 (0)0 (0)
Systemic involvement, no. (%)
ocular involvement8 (7.34)5 (7.58)1 (5.26)2 (8.33)0.923
vascular involvement6 (5.50)4 (6.06)0 (0)2 (8.33)
neurological involvement3 (2.75)1 (1.52)1 (5.26)1 (4.17)0.605
blood involvement5 (4.59)3 (4.55)0 (0)2 (8.33)
Intestinal symptoms61 (55.96)32 (48.48)13 (68.42)16 (66.67)0.149
Endoscopic characteristics, no. (%)
Number, ≥ 362 (56.88)22 (33.33)13 (68.42)20 (83.33)0.000
Size, > 1 cm33 (30.28)20 (30.30)4 (21.05)9 (37.50)0.507
Lab parameters, no. (%)
WBC, × 109/L6.40 (5.15–9.20)6.20 (5.28–9.33)6.40 (4.70–8.10)7.10 (4.73–12.98)0.529
Hb, g/L123.00 (107.00–136.00)124.50 (111.25–135.00)126.00 (105.00–138.00)114.00 (102.00–138.75)0.160
PLT, × 109/L230.00 (185.50–299.50)220.00 (184.00–286.50)263.00 (222.00–356.00)249.00 (189.50–300.25)0.762
ESR, mm/h24.00 (10.00–43.50)22.00 (10.00–40.25)15.00 (6.00–40.00)39.00 (20.50–67.75)0.037
CRP, mg/L10.000 (3.750–37.485)10.000 (3.875–18.925)10.00 (0.80–14.50)21.50 (5.15–54.15)0.116
Positive FOBT+23 (21.10)10 (15.15)6 (31.58)7 (29.17)0.166
Positive T-SPOT19 (17.43)13 (19.70)4 (21.05)2 (8.33)0.409
HBV-DNA6 (5.50)4 (6.06)2 (10.53)0 (0)
  1. +FOBT: fecal occult blood test